Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia

Blood

Volumn 95, Issue 8, 2000, Pages 2651-2658

  Donovan, John W ^a   Ladetto, Marco ^b   Zou, Guangyong ^b   Neuberg, Donna ^b   Poor, Christina ^b   Bowers, Dorothy ^b   Gribben, John G ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTICLE; CANCER RISK; CHILDHOOD CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0034655973     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.8.2651.008k03_2651_2658     Document Type: Article

References (36)

1. Macintyre EA, d'Auriol L, Duparc N, Leverger G, Galibert F, Sigaux F. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias. J Clin Invest. 1990;86:2125.
2. Deane M, McCarthy KP. Wiedemann LM, Norton JD. An improved method for detection of B-lymphoid clonality by polymerase chain reaction. Leukemia. 1991;5:726.
3. Brisco MJ, Condon J, Sykes PJ, Neoh SH, Morley AA. Detection and quantitation of neoplastic cells in acute lymphoblastic leukaemia by use of the polymerase chain reaction. Br J Haematol. 1991;79:211.
4. Steenbergen EJ, Verhagen OJ, van Leeuwen EF, et al. IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL. Leukemia. 1995;9:216.
5. Cavé H, van der Werff ten Bosch J, Suciu S, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer - Childhood Leukemia Cooperative Group. N Engl J Med. 1998;339:591.
6. Cavé H, Guidal C, Rohrlich P, et al. Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of δ and γ T-cell receptor genes. Blood. 1994;83:1892.
7. Gruhn B, Hongeng S, Yi H, et al. Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome. Leukemia. 1999;12:675.
8. van Dongen JJ, Seriu T, Panzer-Grumayer ER, et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet. 1998;352:1731.
9. Gribben JG. Attainment of molecular remission - a worthwhile goal. J Clin Oncol. 1994;12: 1532.
10. Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia [see comments]. N Engl J Med. 1997;336:317.
11. Nucifora G, Larson RA, Rowley JD. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood. 1993;82:712.
12. Price CGA, Meerabux J, Murtagh S, et al. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol. 1991;9:1527.
13. Coustan-Smith E, Behm FG, Sanchez J, et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet. 1998;351:550.
14. Estrov Z, Freedman MH. Detection of residual disease in acute lymphoblastic leukemia of childhood. Leuk Lymphoma. 1999;33:47.
15. Cross NC. Quantitative PCR techniques and applications. Br J Haematol. 1995;89:693.
16. Elsworth AM, Evans PA, Morgan GJ, Kinsey SE, Shiach CR. Quantitative PCR of the immunoglobulin heavy chain gene using genomic DNA. Br J Haematol. 1996;95:700.
17. Vescio RA, Han EJ, Schiller GJ, et al. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts. Bone Marrow Transplant. 1996;18:103.
18. Martin G, Mairs RJ. Synthesis of quantitation standards for nested competitive PCR for the determination of minimal residual disease in B-lineage acute lymphoblastic leukaemia. Leuk Res. 1997;21:807.
19. Orlando C, Pinzani P, Pazzagli M. Developments in quantitative PCR. Clin Chem Lab Med. 1998; 36:255.
20. Slade MJ, Smith BM, Sinnett HD, Cross NC, Coombes RC. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol. 1999; 17:870.
21. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′→3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A. 1991;88:7276.
22. Lee LG, Connell CR, Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 1993;21:3761.
23. Gerard CJ, Arboleda MJ, Solar G, Mule JJ, Kerr WG. A rapid and quantitative assay to estimate gene transfer into retrovirally transduced hematopoietic stem/progenitor cells using a 96-well format PCR and fluorescent detection system universal for MMLV-based proviruses. Hum Gene Ther. 1996;10:343.
24. Luthra R, McBride JA, Cabanillas F, Sarris A. Novel 5′ exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma. Am J Pathol. 1998;153:63.
25. Dolken L, Schuler F, Dolken G. Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes. Biotechniques. 1998;25:1058.
26. Mensink E, van de Locht A, Scattenberg A, et al. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. Br J Haematol. 1998;102:768.
27. Marcucci G, Livak KJ, Bi W, Strout MP, Bloomfield CD, Caligiuri M. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay. Leukemia. 1998;12:1482.
28. Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, et al. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific Taq-Man probes. Leukemia. 1998;12:2006.
29. Higuchi R: Simple and rapid preparation of samples for PC. In: Erlich HA, ed. PCR Technology. New York, NY: Stockton Press; 1989.
30. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 1989;339:237.
31. Andersen NS, Donovan JW, Borus JS, et al. Failure of immunologic purging in mantle cell lymphoma assessed by PCR detection of minimal residual disease. Blood. 1997;90:4212.
32. Hollander M, Wolfe DA. Nonparametric Statistical Methods. 2nd ed. New York, NY: J. Wiley; 1999.
33. Gerard CJ, Olsson K, Ramanathan R, Reading C, Hanania EG. Improved quantitation of minimal residual disease in multiple myeloma using realtime polymerase chain reaction and plasmid-DNA complementarity determining region III standards. Cancer Res. 1998;56:3957.
34. Beutler E, Gelbart T, Kuhl W. Interference of heparin with the polymerase chain reaction. Biotechniques. 1990;9:166.
35. Bahler DW, Levy R. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc Natl Acab Sci U S A. 1992;89:6770.
36. Sahota SS, Leo R, Hamblin TJ, Stevenson FK. Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. Blood. 1997;89:219.